We estimated the prevalence of human immunodeficiency virus (HIV) disclosure in children from a prospective observational cohort study conducted at clinical sites in Brazil, Mexico, and Peru. Fewer than half of the children in this study knew their HIV status, which highlights the need for better strategies for disclosure that are age and culturally appropriate.
In Latin America, an estimated 33 000 children younger than 15 years are living with human immunodeficiency virus (HIV) [1] ; the vast majority of these children acquired HIV through mother-to-child transmission. Because the availability of antiretroviral therapy coverage has increased in low-to middle-income countries (LMCs), HIV-infected children are living longer, which increases the necessity for providing appropriate medical and mental health care for these younger populations and their families. An area that requires further study on a global level is when and how best to inform children about their illness. According to World Health Organization (WHO) guidelines and the American Academy of Pediatrics, advising school-aged (6-to 12-year-old) children of their HIV-positive status (ie, disclosure) is recommended, with considerations for accommodating various levels of cognitive skill and emotional maturity [2, 3] . Other relevant factors that often motivate disclosure include the child's health status and the child's direct inquiries regarding the need for medications and clinic visits.
Despite recommendations for disclosure and its potential beneficial effects on the physical and mental health of HIV-positive children, the proportion of those who know their status remains low [4, 5] . Authors of a review of studies that included estimates of proportions of children who knew their diagnosis reported a range of 1.2% to 75% (median, 29.5%). The proportions of children who knew their diagnosis were lower in studies conducted in LMCs than in industrialized countries (median, 20.4% vs 43.1%, respectively; P = .04). Furthermore, children from LMCs who knew their status tended to be older than those from industrialized countries (median, 9.6 vs 8.3 years, respectively; P = .09). To our knowledge, there have been no published studies on the rates of disclosure in Latin American children with HIV. In this study, we estimated the prevalence of school-aged children who knew their HIV-infection status and identified clinical and demographic characteristics associated with disclosure in HIV-infected children from Latin America. With a greater understanding of the prevalence of and characteristics associated with disclosure, interventions to implement age-and culturally appropriate methods of disclosure to children in resource-limited settings can be developed.
METHODS
The Eunice Kennedy Shriver National Institute of Child Health and Human Development International Site Development Initiative Pediatric Latin American Countries Epidemiologic Study (PLACES) is an observational prospective cohort study to document the demographic, clinical, immunologic, and virologic characteristics of HIV-infected children at participating clinical sites in Brazil, Mexico, and Peru. Data were collected using standardized case-report forms specifically designed for this study.
The analyses reported in this study included the subset of vertically HIV-infected children of school age (≥5 years at enrollment) who were enrolled in 2008-2009. Participants underwent routine medical history and clinical evaluations at visits scheduled at 6-month intervals. Each child's caregiver was asked at study enrollment and follow-up visits if the child knew his or her HIV-infection status and, if so, the age at which the status was disclosed to the child.
RESULTS
Among 500 children enrolled in the PLACES, 236 were eligible for this analysis on the basis of their age at enrollment (≥5 years, which corresponds to the youngest age at which a disclosure occurred in the Eunice Kennedy Shriver National Institute of Child Health and Human Development International Site Development Initiative database). Children were enrolled in the study for a mean duration of 33 months (standard deviation, 5 months). The prevalence of disclosure at enrollment was 21.2% (95% Clopper-Pearson confidence interval [CI], 16.2%-27.0%; age range, 5-11 years); most (82%) disclosures occurred at ≥8 years of age. Of those who did not know their status at enrollment, 22.6% (42) were made aware during study follow-up, and most (93%) disclosures made while the child was on-study occurred at ≥9 years of age. The mean age at the time of disclosure among those who ever knew their HIV status was 9.2 years (median, 9 years; range, 5-13 years). The mean age at the time of last study visit for children whose status was not disclosed to them was 9.1 years (median, 8 years; range, 6-13 years).
The prevalence of disclosure for the entire sample by the time of their last PLACES visit was 39.0% (95% CI, 32.7%-45.5%). The prevalences of disclosure by the last study visit reported separately according to country were 40.7% (77 of 189; 95% CI, 33.7%-48.1%), 38.5 (15 of 39; 95% CI, 23.4%-55.4%), and 0% (0 of 8; 95% CI, 0.0%-36.9%) for Brazil, Mexico, and Peru, respectively. The mean ages at the time of disclosure among those who ever knew their HIV status were 9.3 and 9.1 years for Brazil and Mexico, respectively. None of the 8 participants from Peru were given disclosure regarding their HIV status (all of them were 5 years old at study enrollment).
Characteristics significantly associated with children's knowledge of their HIV status (Table 1) included fewer years of formal education completed by the primary caregiver (P = .04); lower education was associated with higher proportions of children who knew their HIV status. The vital status of the biological father also was significantly associated with disclosure (P = .03); a greater proportion of children whose biological father was deceased knew their HIV status. Mean log 10 viral load at baseline and the proportion of children who had been prescribed antiretroviral medication were also significantly associated with HIV disclosure status.
DISCUSSION
Fewer than half of the children (aged 5-14 years) included in this study, conducted in Latin American countries, knew their HIV status. This prevalence rate is lower than that observed in most studies. The low rates in these Latin American clinical sites highlight the need in resource-limited settings for more studies on the effects of disclosure to better characterize an appropriate process for disclosure that also incorporates the cultural context of the child and his or her family [6] .
In this study, conducted in Latin America, disclosure of HIV status was significantly and inversely associated with educational level of the primary caregiver. This finding lends additional support for the need for evidence-based guidance and support for caregivers in disclosing HIV-infection status to their child using materials that are appropriate to the caregiver's level of education. Guidance on the disclosure process also needs to take into consideration cultural and contextual issues, such as the dynamics of the family [7] [8] [9] . For example, in Latino cultures, the definition of family often extends to multigenerational members, particularly grandparents; therefore, their roles in the caretaking aspects of their grandchildren need to be considered during the disclosure process. Overall, disclosure should be considered a collaborative process that involves the entire family and multidisciplinary health care team with the support of national evidence-based guidelines.
We also found a significant association between disclosure and the vital status of the child's biological father. Because we did not collect information from the caregiver regarding the cause of the biological father's death and/or the timing of the death in relation to the child's age of disclosure, the clinical significance of this association needs further investigation; it should be noted that the vital status of the biological father was unknown for 14% of children in the overall sample. The death of the child's father could have served as a motivator to disclose the child's illness to encourage the child to take better care of his or her own health, such as by improving adherence to antiretroviral medications. It is also possible that the death of the child's father left the surviving mother with a need for additional support regarding the child, which prompted disclosure of the child's HIV infection. Additional studies are needed to better understand the relationship between a caregiver's vital and health status and subsequent disclosure to the child.
Finally, because the age at which the child learned of his or her HIV diagnosis might have preceded study enrollment, clinical predictors as influencing factors for HIV disclosure could not be assessed within this study. However, it is of interest to report that those children who did not know their HIV status at study enrollment had the highest mean viral load. Of course, this finding is not unexpected, because it was less likely for those children who did not know their HIV status to be prescribed antiretroviral medications at enrollment. Taken together, these findings indicate that disclosure of their HIV-infection status to a child might have positive effects on medication adherence and thus viral suppression. Additional areas that need further investigation in school-aged children with HIV infection are the numbers of those who, unbeknownst to their caregiver, already know their HIV status, whether study participation influenced disclosure, and postdisclosure assessments of the child to ascertain mental health, social, academic, and family functioning.
Despite World Health Organization recommendations that school-aged children be told of their HIV diagnosis, reported rates of disclosure from this observational study conducted in 3 Latin American countries among a group of HIV-infected children aged 5 years or older remain low. Significant gaps exist in research and knowledge regarding disclosure rates in developing countries and low-resource settings, and gaps regarding ageand culturally appropriate processes for disclosure also exist [10] . Additional research to identify characteristics associated with children's knowledge of their HIV status in Latin America and other resource-limited settings in which the HIV epidemic persists is needed to guide interventions aimed at increasing disclosure rates and providing support to HIV-infected children and their families [11, 12] . 
